Attorney General Charity Clark today announced that Vermont has joined 41 other states in reaching a nationwide settlement of $102.5 million with the maker of Suboxone, Indivior Inc. Vermont will receive about $2 million from the settlement, which resolves allegations that Indivior used illegal means to switch the Suboxone market from tablets to film while attempting to destroy the market for tablets to preserve its drug monopoly. Suboxone is a brand name for buprenorphine, a medication used to treat opioid use disorder.
“Suboxone has been a critical drug to help those experiencing opioid use disorder enter into successful recovery,” said Attorney General Clark. “The market for such an important drug must be free from monopoly tactics, which are never acceptable.”
The agreement, which was submitted to the court in the Eastern District of Pennsylvania for approval, requires Indivior to pay $102.5 million and comply with negotiated injunctive terms designed to ensure that Indivior refrains from engaging in conduct intended to prevent competition for their products.
Attorney General Clark is joined in the settlement by the attorneys general of Alabama, Alaska, Arkansas, California, Colorado, District of Columbia, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Nebraska, New Hampshire, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Utah, Virginia, Washington, West Virginia, and Wisconsin.
A copy of the settlement is available here.
CONTACT: Lauren Jandl, Chief of Staff, 802-828-3171